Back

The specific characteristics and independent predictors of no-reflow phenomenon, development of a clinically-adaptable risk estimation system

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock Complications ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Fanni Banfi-Bacsardi

Gottsegen National Cardiovascular Center, Budapest (Hungary)

26 More presentations in this session

Presentation thumbnail
Doctor D. Topal (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Doctor A. Pavlovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Doctor C. O'connor (Limerick, IE)
Abstract Slides
Presentation thumbnail
Associate Professor D. Maximkin (Moscow, RU)
Abstract
Presentation thumbnail
Doctor D. Milasinovic (Belgrade, RS)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Usefulness of canada acute coronary syndrome risk score for predicting no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
28 August 2023
thumbnail
Congress Presentation
Inflammatory biomarkers prognostic role in patients with heart failure and peripheral artery disease undergoing cardiac rehabilitation
20 May 2023
thumbnail
Congress Presentation
Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention
27 August 2021
thumbnail
Congress Presentation
A macrophage migration inhibitory factor as a predictor of no-reflow phenomenon and other adverse events in patients with st-segment elevation myocardial infarction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources